TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy

Rebecca S. Bahn

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The TSH receptor (TSHr) is the autoantigen responsible for the hyperthyroidism of Graves' disease. Recent studies suggest that this receptor may also be an autoimmune target in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). Its involvement in the pathogenesis of these conditions would help to explain the close clinical associations between hyperthyroidism, GO and PTD. TSHr has been shown to be present in normal orbital and dermal tissues and evidence supports the conviction that expression may be increased in tissues involved in GO and PTD. In the setting of Graves' disease, the expression of this antigen in connective tissues throughout the body may lead to systemic, subclinical connective tissue inflammation. Given this background, local or environmental factors such as circulating or local cytokines, gravitational dependency, anatomic constraint of the bony orbit, or trauma, may augment clinical disease involvement within the orbit and pretibial skin. Alternately, locally enhanced expression of this protein at the sites of clinical disease may not be directly involved in pathogenesis, but could be secondary to the ongoing process, and nonetheless important in disease progression.

Original languageEnglish (US)
Pages (from-to)216-220
Number of pages5
JournalJournal of Endocrinological Investigation
Volume27
Issue number3
StatePublished - Mar 2004

Fingerprint

Graves Ophthalmopathy
Thyrotropin Receptors
Graves Disease
Orbit
Hyperthyroidism
Connective Tissue
Skin
Autoantigens
Disease Progression
Cytokines
Inflammation
Antigens
Wounds and Injuries
Proteins

Keywords

  • Graves' disease
  • Graves' ophthalmopathy
  • TSH receptor

ASJC Scopus subject areas

  • Endocrinology

Cite this

TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy. / Bahn, Rebecca S.

In: Journal of Endocrinological Investigation, Vol. 27, No. 3, 03.2004, p. 216-220.

Research output: Contribution to journalArticle

@article{0cc4e9838bbe4239b2d1fa17ba0a203f,
title = "TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy",
abstract = "The TSH receptor (TSHr) is the autoantigen responsible for the hyperthyroidism of Graves' disease. Recent studies suggest that this receptor may also be an autoimmune target in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). Its involvement in the pathogenesis of these conditions would help to explain the close clinical associations between hyperthyroidism, GO and PTD. TSHr has been shown to be present in normal orbital and dermal tissues and evidence supports the conviction that expression may be increased in tissues involved in GO and PTD. In the setting of Graves' disease, the expression of this antigen in connective tissues throughout the body may lead to systemic, subclinical connective tissue inflammation. Given this background, local or environmental factors such as circulating or local cytokines, gravitational dependency, anatomic constraint of the bony orbit, or trauma, may augment clinical disease involvement within the orbit and pretibial skin. Alternately, locally enhanced expression of this protein at the sites of clinical disease may not be directly involved in pathogenesis, but could be secondary to the ongoing process, and nonetheless important in disease progression.",
keywords = "Graves' disease, Graves' ophthalmopathy, TSH receptor",
author = "Bahn, {Rebecca S.}",
year = "2004",
month = "3",
language = "English (US)",
volume = "27",
pages = "216--220",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "3",

}

TY - JOUR

T1 - TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy

AU - Bahn, Rebecca S.

PY - 2004/3

Y1 - 2004/3

N2 - The TSH receptor (TSHr) is the autoantigen responsible for the hyperthyroidism of Graves' disease. Recent studies suggest that this receptor may also be an autoimmune target in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). Its involvement in the pathogenesis of these conditions would help to explain the close clinical associations between hyperthyroidism, GO and PTD. TSHr has been shown to be present in normal orbital and dermal tissues and evidence supports the conviction that expression may be increased in tissues involved in GO and PTD. In the setting of Graves' disease, the expression of this antigen in connective tissues throughout the body may lead to systemic, subclinical connective tissue inflammation. Given this background, local or environmental factors such as circulating or local cytokines, gravitational dependency, anatomic constraint of the bony orbit, or trauma, may augment clinical disease involvement within the orbit and pretibial skin. Alternately, locally enhanced expression of this protein at the sites of clinical disease may not be directly involved in pathogenesis, but could be secondary to the ongoing process, and nonetheless important in disease progression.

AB - The TSH receptor (TSHr) is the autoantigen responsible for the hyperthyroidism of Graves' disease. Recent studies suggest that this receptor may also be an autoimmune target in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). Its involvement in the pathogenesis of these conditions would help to explain the close clinical associations between hyperthyroidism, GO and PTD. TSHr has been shown to be present in normal orbital and dermal tissues and evidence supports the conviction that expression may be increased in tissues involved in GO and PTD. In the setting of Graves' disease, the expression of this antigen in connective tissues throughout the body may lead to systemic, subclinical connective tissue inflammation. Given this background, local or environmental factors such as circulating or local cytokines, gravitational dependency, anatomic constraint of the bony orbit, or trauma, may augment clinical disease involvement within the orbit and pretibial skin. Alternately, locally enhanced expression of this protein at the sites of clinical disease may not be directly involved in pathogenesis, but could be secondary to the ongoing process, and nonetheless important in disease progression.

KW - Graves' disease

KW - Graves' ophthalmopathy

KW - TSH receptor

UR - http://www.scopus.com/inward/record.url?scp=2342460210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342460210&partnerID=8YFLogxK

M3 - Article

C2 - 15164996

AN - SCOPUS:2342460210

VL - 27

SP - 216

EP - 220

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 3

ER -